Literature DB >> 27876627

IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level.

Régis Joulia1, Fatima-Ezzahra L'Faqihi1, Salvatore Valitutti1, Eric Espinosa2.   

Abstract

BACKGROUND: Mast cells are versatile key components of allergy and inflammation known to respond to both innate and adaptive immunologic stimuli. However, the response of individual mast cells to cumulative stimuli remains poorly understood.
OBJECTIVES: We sought to dissect mast cell responses at the single-cell level and their potentiation by IL-33.
METHODS: We monitored mast cell degranulation in real time by exploiting the capacity of fluorochrome-labeled avidin to stain degranulating cells. During the degranulation process, the granule matrix is externalized and immediately bound by fluorochrome-labeled avidin present in the culture medium. The degranulation process is monitored by using either time-lapse microscopy or fluorescence-activated cell sorting analysis.
RESULTS: Single-cell analysis revealed a strong heterogeneity of individual mast cell degranulation responses. We observed that the number of degranulating mast cells was graded according to the FcεRI stimulation strength, whereas the magnitude of individual mast cell degranulation remained unchanged, suggesting an all-or-none response of mast cells after FcεRI triggering. IL-33 pretreatment increased not only the number of degranulating and chemokine-producing mast cells but also the magnitude of individual mast cell degranulation and chemokine production.
CONCLUSION: We illustrate the effect of IL-33 on mast cell biology at the single-cell level by showing that IL-33 potentiates IgE-mediated mast cell responses by both increasing the number of responding cells and enhancing the responses of individual mast cells.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-33; Mast cells; avidin; degranulation; time-lapse flow cytometry

Mesh:

Substances:

Year:  2016        PMID: 27876627     DOI: 10.1016/j.jaci.2016.09.049

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  29 in total

Review 1.  Role of myeloid cells in the regulation of group 2 innate lymphoid cell-mediated allergic inflammation.

Authors:  Aihua Lei; Yumei He; Qiong Yang; Xiaofang Li; Ranhui Li
Journal:  Immunology       Date:  2020-08-03       Impact factor: 7.397

2.  IL-33/ST2 signaling boosts inflammation and pain.

Authors:  Victor Fattori; Sergio M Borghi; Waldiceu A Verri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

3.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

4.  IL-33/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients.

Authors:  Carina G Uasuf; Caterina Di Sano; Sebastiano Gangemi; Giuseppe Albeggiani; Diego Cigna; Paola Dino; Ignazio Brusca; Mark Gjomarkaj; Elisabetta Pace
Journal:  Inflamm Res       Date:  2018-05-17       Impact factor: 4.575

Review 5.  The transcriptional program, functional heterogeneity, and clinical targeting of mast cells.

Authors:  Gökhan Cildir; Harshita Pant; Angel F Lopez; Vinay Tergaonkar
Journal:  J Exp Med       Date:  2017-08-15       Impact factor: 14.307

Review 6.  Genetic and Imaging Approaches Reveal Pro-Inflammatory and Immunoregulatory Roles of Mast Cells in Contact Hypersensitivity.

Authors:  Nicolas Gaudenzio; Thomas Marichal; Stephen J Galli; Laurent L Reber
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

7.  Soluble transforming growth factor beta-1 enhances murine mast cell release of Interleukin 6 in IgE-independent and Interleukin 13 in IgE-dependent settings in vitro.

Authors:  David O Lyons; Michele R Plewes; Nicholas A Pullen
Journal:  PLoS One       Date:  2018-11-16       Impact factor: 3.240

8.  MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.

Authors:  Magda Babina; Zhao Wang; Saptarshi Roy; Sven Guhl; Kristin Franke; Metin Artuc; Hydar Ali; Torsten Zuberbier
Journal:  J Invest Dermatol       Date:  2020-10-13       Impact factor: 8.551

9.  IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis.

Authors:  J Travers; M Rochman; J M Caldwell; J A Besse; C E Miracle; M E Rothenberg
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

10.  S1P₄ Regulates Passive Systemic Anaphylaxis in Mice but Is Dispensable for Canonical IgE-Mediated Responses in Mast Cells.

Authors:  Joseph M Kulinski; Richard L Proia; Elisabeth M Larson; Dean D Metcalfe; Ana Olivera
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.